Market revenue in 2021 | USD 74.7 million |
Market revenue in 2028 | USD 227.8 million |
Growth rate | 17.3% (CAGR from 2021 to 2028) |
Largest segment | Left ventricular assist devices |
Fastest growing segment | Total Artificial Heart (TAH) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Left ventricular assist devices, Right ventricular assist devices, Bi-ventricular assist devices, Total Artificial Heart (TAH) |
Key market players worldwide | Johnson & Johnson, Medtronic PLC, Abbott Laboratories, Cardio Diagnostics Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ventricular assist device market will help companies and investors design strategic landscapes.
Left ventricular assist devices was the largest segment with a revenue share of 80.59% in 2021. Horizon Databook has segmented the France ventricular assist device market based on left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, total artificial heart (tah) covering the revenue growth of each sub-segment from 2018 to 2028.
According to WHO report 2017, burden of various heart diseases such as strokes, coronary heart diseases, and ischemic heart attacks in France is high. For instance, about 3.9 million deaths were reported in 2017 and about 1.8 million deaths were recorded in EU due to high prevalence of CVDs.
Moreover, according to Stroke Alliance for Europe, the prevalence of stroke have reached to 366,129 in France and about 57,174 cases were registered in the past years. In addition, as per Tobacco Atlas, every year about 73,500 people are affected by numerous heart diseases due to high consumption of tobacco and alcohol.
These aforementioned factors have boosted the adoption of VADs thereby, aiding market growth. Furthermore, increasing number of collaborations between government bodies and major players to provide solutions for increasing heart diseases is expected to propel the market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the France ventricular assist device market , including forecasts for subscribers. This country databook contains high-level insights into France ventricular assist device market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account